Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

37.92
Delayed Data
As of Oct 20
 +0.81 / +2.18%
Today’s Change
26.16
Today|||52-Week Range
46.81
+23.04%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close37.11
Today’s open37.38
Day’s range37.18 - 38.47
Volume367,742
Average volume (3 months)387,158
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+34.47%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+25.14%
P/E ratio74.4
Price/Sales10.05
Price/Book7.60

Competitors

 Today’s
change
Today’s
% change
MYOKMyoKardia Inc-0.90-2.38%
ARRYArray Biopharma Inc-0.26-2.29%
LXRXLexicon Pharmaceutic...-0.18-1.59%
EBSEmergent BioSolution...+0.28+0.69%
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.11
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts